Director Graf R. Mark receives 21,872 HRMY stock options in new equity grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Harmony Biosciences Holdings director Graf R. Mark received a new stock option grant covering 21,872 shares of common stock. The options have an exercise price of $30.76 per share and expire on May 14, 2036. They vest in full on the earlier of May 14, 2027 or the next annual meeting, subject to his continued service. After this grant, he holds 21,872 stock options directly according to this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Graf R. Mark

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	21,872	$0.00	--

Holdings After Transaction: Stock Option — 21,872 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 21,872 options Exercise price: $30.76 per share Expiration date: May 14, 2036 +3 more

6 metrics

Option grant size 21,872 options Stock option award to director Graf R. Mark

Exercise price $30.76 per share Conversion/exercise price of granted options

Expiration date May 14, 2036 Option term end for this grant

Vesting date trigger May 14, 2027 or next annual meeting Full vesting, subject to continued service

Post-grant derivative holdings 21,872 options Total options held directly after transaction

Transaction price paid $0.00 per option Grant/award acquisition, no purchase price

Key Terms

Stock Option, grant/award acquisition, underlying security, vesting, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

underlying security financial

"underlying_security_title: "Common Stock""

vesting financial

"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: "30.7600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 04:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Graf R. Mark

(Last)

(First)

(Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

630 W GERMANTOWN PIKE, SUITE 215

(Street)

PLYMOUTH MEETING

PENNSYLVANIA

19462

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$30.76	05/14/2026		A		21,872		⁽¹⁾	05/14/2036	Common Stock	21,872	$0	21,872	D

Explanation of Responses:

1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Harmony Biosciences (HRMY) report for Graf R. Mark?

Harmony Biosciences reported that director Graf R. Mark received a stock option grant for 21,872 shares of common stock. This is a compensation-related award rather than an open-market trade, reflecting additional equity-based incentive tied to the company’s share price performance.

What is the exercise price of Graf R. Mark’s new HRMY stock options?

The granted stock options have an exercise price of $30.76 per share. This means he can buy Harmony Biosciences common stock at $30.76 once the options vest, if exercising before the May 14, 2036 expiration date.

When do Graf R. Mark’s Harmony Biosciences stock options vest?

The stock options vest in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant. Vesting is contingent on his continued service through the applicable vesting date, aligning incentives with ongoing board service.

When do Graf R. Mark’s newly granted HRMY stock options expire?

The stock options expire on May 14, 2036. After that date, any unexercised options will no longer be usable, so potential benefits from the grant depend on Harmony Biosciences’ share price and his exercise decisions before expiration.

How many Harmony Biosciences options does Graf R. Mark hold after this grant?

Following this transaction, Graf R. Mark holds 21,872 stock options directly according to the filing. This amount matches the newly granted options, indicating his derivative position in Harmony Biosciences common stock is fully represented by this single award.